1. Promising therapeutic targets for treatment of rheumatoid arthritis;Huang;Front. Immunol.,2021
2. The therapeutic landscape of rheumatoid arthritis: current state and future directions;Shams;Front. Pharmacol.,2021
3. Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study;Vicente;Adv. Rheumatol.,2021
4. Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the pre-clinical evaluation of novel targets in RA (PREVeNT;Costello;Arthritis Res. Ther.,2021
5. Significantly improving the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations;Ma;Adv. Mater.,2021